Abstract 4146814: Heart failure is time-dependent and associated with heart transplant, hepatocellular carcinoma, and death in the Fontan population

Background: The Fontan operation has been an effective treatment plan for patients with single ventricle anomalies, greatly improving survival into adulthood. Yet, Fontan patients are at increased risk of numerous cardiac and noncardiac complications, and premature mortality. Methods: A cohort of 735 patients with a prior Fontan surgery (median age 7.6yrs at first encounter, 57.4% male, 41.0% Black), with at least one healthcare encounter from a pediatric or adult healthcare system between 2010-2019, was linked to encounter data and death certificates. Heart failure (HF) was defined by ICD-9-CM and ICD-10-CM codes determined by clinicians. The primary composite outcome included heart transplant, hepatocellular carcinoma (HCC) and death. Hospitalizations were defined as an inpatient encounter spanning at least two consecutive days. Time to event was anchored at initial encounter. Results: Characteristics of those with and without HF are seen in Table 1. Median age was 17.1yrs [3.0-70.5] and 5.5yrs [3.0-56.0] for those with and without HF, respectively. The composite outcome occurred in 85 Fontan patients (11.6%) at median 3.26yrs after initial encounter. Of those with HF, 12.5% experienced a heart transplant compared to 0.9% without HF (p<0.001), 3.0% with HF had HCC vs 0.5% without HF (p<0.05), and 9.4% with HF died at mean age 29.3yrs compared to 2.7% without HF at mean age 16.3yrs (p<0.001). Kaplan-Meier event-free survival curves appear in Figure 1. Of those with HF, 69.0% were hospitalized at least once compared to 53.0% of those without HF (p<0.001). Fontan patients without HF were 95.9% likely to be event-free at 5yrs follow-up compared to those with HF who were 84.7% likely to be event-free at 5yrs. Conclusion: Fontan patients more commonly experience HF at older ages. HF is associated with heart transplant, HCC, and death during follow-up compared with Fontan patients without HF. Hospitalizations were common in both groups, but occurred more commonly with HF.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2024-11-12
DOI
https://doi.org/10.1161/circ.150.suppl_1.4146814
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4146814: Heart failure is time-dependent and associated with heart transplant, hepatocellular carcinoma, and death in the Fontan population

Lindsey C. Ivey, Wendy Book, Fred H. Rodriguez, Cheryl Raskind‐Hood et al.
Circulation
Transplantation: Methods and Outcomes
article

Abstract 4146814: Heart failure is time-dependent and associated with heart transplant, hepatocellular carcinoma, and death in the Fontan population

Lindsey C. Ivey, Wendy Book, Fred H. Rodriguez, Cheryl Raskind‐Hood, Abeed Sarker, Yuting Guo, Andreas C. Häffner
article en

Abstract

Background: The Fontan operation has been an effective treatment plan for patients with single ventricle anomalies, greatly improving survival into adulthood. Yet, Fontan patients are at increased risk of numerous cardiac and noncardiac complications, and premature mortality. Methods: A cohort of 735 patients with a prior Fontan surgery (median age 7.6yrs at first encounter, 57.4% male, 41.0% Black), with at least one healthcare encounter from a pediatric or adult healthcare system between 2010-2019, was linked to encounter data and death certificates. Heart failure (HF) was defined by ICD-9-CM and ICD-10-CM codes determined by clinicians. The primary composite outcome included heart transplant, hepatocellular carcinoma (HCC) and death. Hospitalizations were defined as an inpatient encounter spanning at least two consecutive days. Time to event was anchored at initial encounter. Results: Characteristics of those with and without HF are seen in Table 1. Median age was 17.1yrs [3.0-70.5] and 5.5yrs [3.0-56.0] for those with and without HF, respectively. The composite outcome occurred in 85 Fontan patients (11.6%) at median 3.26yrs after initial encounter. Of those with HF, 12.5% experienced a heart transplant compared to 0.9% without HF (p<0.001), 3.0% with HF had HCC vs 0.5% without HF (p<0.05), and 9.4% with HF died at mean age 29.3yrs compared to 2.7% without HF at mean age 16.3yrs (p<0.001). Kaplan-Meier event-free survival curves appear in Figure 1. Of those with HF, 69.0% were hospitalized at least once compared to 53.0% of those without HF (p<0.001). Fontan patients without HF were 95.9% likely to be event-free at 5yrs follow-up compared to those with HF who were 84.7% likely to be event-free at 5yrs. Conclusion: Fontan patients more commonly experience HF at older ages. HF is associated with heart transplant, HCC, and death during follow-up compared with Fontan patients without HF. Hospitalizations were common in both groups, but occurred more commonly with HF.

CirculationVol. 150(Suppl_1)
Emory University (US), Emory Clinic (US), Catholic Legal Immigration Network (US)
Good health and well-being
Openalex Percentile: Top 61%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.